Association Between Matrix Metalloproteinase-2 Gene Polymorphism rs243865 and Susceptibility to Cataract Development
NCT05670834 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 90
Last updated 2024-07-23
Summary
The primary aim of this study is to investigate the potential association between MMP-2 gene polymorphism and susceptibility to cataract development in Egyptian patients. Furthermore, this study aims to compare between cataract patients and healthy controls by measuring the serum IL-6 concentration to evaluate its relationship with disease.
Conditions
- Cataract
Interventions
- GENETIC
-
genotyping assay by real-time PCR
genotyping assay of MMP-2 gene with the real-time polymerase chain reaction
- DIAGNOSTIC_TEST
-
ELISA
. IL-6 level in serum will be analyzed by ELISA assay kit.
Sponsors & Collaborators
-
Sohag University
lead OTHER
Eligibility
- Min Age
- 21 Years
- Sex
- ALL
- Healthy Volunteers
- No
Timeline & Regulatory
- Start
- 2023-07-01
- Primary Completion
- 2024-01-30
- Completion
- 2024-04-30
Countries
- Egypt
Study Locations
More Related Trials
-
Ocular Inflammation in Cataract Patients and Response to Treatment With Xiidra
NCT04120987 ·Status: WITHDRAWN ·Phase: PHASE4
-
Efficacy and Safety of XG-102 in Reduction of Post-cataract Surgery Intraocular Inflammation
NCT02235272 ·Status: COMPLETED ·Phase: PHASE3
-
Loteprednol Etabonate Ophthalmic Gel for the Treatment of Ocular Inflammation and Pain Following Cataract Surgery
NCT02208297 ·Status: COMPLETED ·Phase: PHASE3
-
The Role of Prostaglandins in the Progression of Diabetic Retinopathy
NCT01609881 ·Status: WITHDRAWN ·Phase: PHASE1
-
Aqueous Concentrations and PGE2 Inhibition of Ketorolac 0.4% vs. Bromfenac 0.09% in Cataract Patients: Trough Drug Effects
NCT00469690 ·Status: COMPLETED ·Phase: PHASE4
-
Effect of Cequa Treatment on Accuracy of Pre-operative Biometry & Higher Order Aberrations in Dry Eye Patients Undergoing Cataract Surgery
NCT04342988 ·Status: COMPLETED ·Phase: PHASE4
-
Safety and Tolerability of the Ophthalmic Solution PRO-156 in Ophthalmologically Healthy Volunteers.
NCT01871077 ·Status: COMPLETED ·Phase: PHASE1
-
Cross-linking of Corneal Collagen (CXL) With Ultraviolet-A in Asymmetric Corneas
NCT01189864 ·Status: TERMINATED
-
Efficacy Study of Bromfenac Ophthalmic Solution in Patients Undergoing Cataract Surgery
NCT00853970 ·Status: COMPLETED ·Phase: PHASE3
-
Loteprednol Etabonate Ophthalmic Ointment vs. Vehicle in the Treatment of Inflammation Following Cataract Surgery
NCT00645671 ·Status: COMPLETED ·Phase: PHASE3
-
Efficacy and Safety of Saturno IIB Association on the Control of Ocular Inflammation Post-phacoemulsification
NCT03580473 ·Status: COMPLETED ·Phase: PHASE2
-
Mapracorat Ophthalmic Suspension, 3% for the Treatment of Ocular Inflammation and Pain Following Cataract Surgery
NCT01591161 ·Status: COMPLETED ·Phase: PHASE3
-
Loteprednol Etabonate Versus Vehicle for the Treatment of Inflammation and Pain Following Cataract Surgery
NCT01010633 ·Status: COMPLETED ·Phase: PHASE3
-
Efficacy of Bromfenac Ophthalmic Solution in Patients Undergoing Cataract Surgery
NCT01367249 ·Status: COMPLETED ·Phase: PHASE3
-
Measurement of Antioxidant Activity on Postoperative Inflammation in Patients Undergoing Ophthalmic Surgery
NCT05905237 ·Status: COMPLETED
-
Efficacy and Safety of APP13007 for Treatment of Inflammation and Pain After Cataract Surgery Including a Corneal Endothelial Cell Sub-study
NCT04810962 ·Status: COMPLETED ·Phase: PHASE3
-
An Observational, Qualitative Study Assessing Eye Drop Administration
NCT05307081 ·Status: UNKNOWN
-
A Comparison of 0.5% Loteprednol Etabonate Versus 1% Prednisolone Acetate Following Cataract Surgery
NCT01384266 ·Status: COMPLETED
-
Protein Profile of Immunoregulatory Factors in Diabetic Cataract
NCT01832311 ·Status: COMPLETED ·Phase: PHASE4
-
Effect of Preoperative Topical Ketorolac on Aqueous Cytokine Levels and Macular Thickness in Cataract Surgery Patients
NCT02646072 ·Status: COMPLETED ·Phase: PHASE4
-
A Comparison of Post Phacoemulsification Aqueous Flare in Patients Using Ketorolac 0.45% 2 Times Daily (BID) and Bromfenac 0.09% 2 Times Daily (BID)
NCT01023724 ·Status: COMPLETED ·Phase: PHASE4
-
A Study to Evaluate the Safety, Tolerability and Preliminary Efficacy of APP13007 to Treat Inflammation and Pain After Cataract Surgery
NCT04089735 ·Status: COMPLETED ·Phase: PHASE2
-
The Effect of a Pre-cataract Surgical Ocular Hygiene Regime on Microbial Load, Tear Osmolarity, Dry Eye, and Inflammatory Markers
NCT05990712 ·Status: UNKNOWN ·Phase: PHASE4
-
Acular LS vs. Nevanac in Post op Inflammation Following Cataract Surgery
NCT00348582 ·Status: COMPLETED ·Phase: PHASE4
-
Loteprednol Etabonate in an Ophthalmic Base vs Vehicle for the Treatment of Inflammation Following Cataract Surgery
NCT00699153 ·Status: COMPLETED ·Phase: PHASE3